Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci.

Almost 100 genetic loci are known to affect serum cholesterol and triglyceride levels. For many of these loci, the biological function and causal variants remain unknown. We performed an association analysis of the reported 95 lipid loci against 216 metabolite measures, including 95 measurements on lipids and lipoprotein subclasses, obtained via serum nuclear magnetic resonance metabolomics and four enzymatic lipid traits in 8330 individuals from Finland. The genetic variation in the loci was investigated using a dense set of 440 807 directly genotyped and imputed variants around the previously identified lead single nucleotide polymorphisms (SNPs). For 30 of the 95 loci, we identified new metabolic or genetic associations (P < 5 × 10(-8)). In the majority of the loci, the strongest association was to a more specific metabolite measure than the enzymatic lipids. In four loci, the smallest high-density lipoprotein measures showed effects opposite to the larger ones, and 14 loci had associations beyond the individual lipoprotein measures. In 27 loci, we identified SNPs with a stronger association than the previously reported markers and 12 loci harboured multiple, statistically independent variants. Our data show considerable diversity in association patterns between the loci originally identified through associations with enzymatic lipid measures and reveal association profiles of far greater detail than from routine clinical lipid measures. Additionally, a dense marker set and a homogeneous population allow for detailed characterization of the genetic association signals to a resolution exceeding that achieved so far. Further understanding of the rich variability in genetic effects on metabolites provides insights into the biological processes modifying lipid levels.

[1]  M. Inouye,et al.  Genome-wide association studies and systems biology: together at last. , 2011, Trends in genetics : TIG.

[2]  C. Gieger,et al.  Human metabolic individuality in biomedical and pharmaceutical research , 2011, Nature.

[3]  Jukka Heikkonen,et al.  Three-Dimensional cryoEM Reconstruction of Native LDL Particles to 16Å Resolution at Physiological Body Temperature , 2011, PloS one.

[4]  W. Annema,et al.  Role of Hepatic Lipase and Endothelial Lipase in High-Density Lipoprotein—Mediated Reverse Cholesterol Transport , 2011, Current atherosclerosis reports.

[5]  Samia Mora,et al.  Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. , 2011, Journal of clinical lipidology.

[6]  P. Elliott,et al.  Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels , 2011, Circulation.

[7]  Paul R. Burton,et al.  Large-Scale Candidate Gene Analysis of HDL Particle Features , 2011, PloS one.

[8]  Emmanouil Collab A map of human genome variation from population-scale sequencing , 2011, Nature.

[9]  Markus Perola,et al.  Metabonomic, transcriptomic, and genomic variation of a population cohort , 2010, Molecular systems biology.

[10]  Michael Inouye,et al.  Founder population-specific HapMap panel increases power in GWA studies through improved imputation accuracy and CNV tagging. , 2010, Genome research.

[11]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[12]  Markus Perola,et al.  An Immune Response Network Associated with Blood Lipid Levels , 2010, PLoS genetics.

[13]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[14]  B. Vergès Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes. , 2010, Atherosclerosis.

[15]  R. Krauss Lipoprotein subfractions and cardiovascular disease risk , 2010, Current opinion in lipidology.

[16]  Christian Gieger,et al.  A genome-wide perspective of genetic variation in human metabolism , 2010, Nature Genetics.

[17]  Christian Gieger,et al.  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.

[18]  P. Ridker,et al.  Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis , 2009, PLoS genetics.

[19]  M. Savolainen,et al.  Letter by Ala-Korpela et al regarding article, "Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women". , 2009, Circulation.

[20]  Thomas Meitinger,et al.  Genetic Determinants of Circulating Sphingolipid Concentrations in European Populations , 2009, PLoS genetics.

[21]  Reino Laatikainen,et al.  High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. , 2009, The Analyst.

[22]  Markus Perola,et al.  OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism , 2009, Journal of Molecular Medicine.

[23]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[24]  Samia Mora,et al.  Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women , 2009, Circulation.

[25]  K. Kaski,et al.  Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs—apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes , 2009, Annals of medicine.

[26]  Risto Telama,et al.  Cohort profile: the cardiovascular risk in Young Finns Study. , 2008, International journal of epidemiology.

[27]  Mika Ala-Korpela,et al.  Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics , 2008, Clinical chemistry and laboratory medicine.

[28]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[29]  M. Jauhiainen,et al.  Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles. , 2007, Biochemistry.

[30]  J. Eriksson,et al.  Epidemiology, genes and the environment: lessons learned from the Helsinki Birth Cohort Study , 2007, Journal of internal medicine.

[31]  M. Jauhiainen,et al.  Absence of endogenous phospholipid transfer protein impairs ABCA1-dependent efflux of cholesterol from macrophage foam cells Published, JLR Papers in Press, May 10, 2006. , 2006, Journal of Lipid Research.

[32]  Chiara Sabatti,et al.  Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies , 2006, Nature Genetics.

[33]  ShizuyaYamashita,et al.  Identification of Unique Lipoprotein Subclasses for Visceral Obesity by Component Analysis of Cholesterol Profile in High-Performance Liquid Chromatography , 2005 .

[34]  D. Capuzzi,et al.  High-density lipoprotein subfractions and risk of coronary artery disease , 2004, Current atherosclerosis reports.

[35]  G. Crepaldi,et al.  Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins. , 2003, Biochemical Society transactions.

[36]  J. Segrest,et al.  Structure of apolipoprotein B-100 in low density lipoproteins. , 2001, Journal of lipid research.

[37]  H. Jamil,et al.  Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. , 2000, Biochimica et biophysica acta.

[38]  J. Wrana,et al.  MAD-related proteins in TGF-β signalling , 1996 .

[39]  References , 1971 .

[40]  P. Rantakallio,et al.  Groups at risk in low birth weight infants and perinatal mortality. , 1969, Acta paediatrica Scandinavica.